Skip to main content

Progesterone

Source index · review incomplete

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated July 17, 2026; this date does not indicate completed review.

Hormones1,583 cited mentions
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on Progesterone; the papers are listed at the end. Research summary, not a recommendation.

What it is

Progesterone is a natural steroid hormone made mainly by the ovary after ovulation (by the corpus luteum), by the placenta in pregnancy, and in small amounts by the adrenal glands. It is made from pregnenolone. Medicinal 'micronized' progesterone is chemically identical to the body's own hormone, which distinguishes it from synthetic progestins such as medroxyprogesterone acetate. It is not a peptide; oral, vaginal and injectable forms are FDA-approved prescription drugs.

How it works

Progesterone acts mainly through progesterone receptors inside cells, which bind DNA and switch target genes on or off. In the uterus it converts the estrogen-built lining into a lining that can receive an embryo, and it counters estrogen's growth signal, which is why it is paired with estrogen in menopausal hormone therapy. In pregnancy it keeps the uterine muscle relaxed and the cervix closed. Its metabolite allopregnanolone acts on GABA-A receptors in the brain, which explains the drowsiness oral progesterone can cause.

What it has been studied for

  • Protecting the uterine lining during estrogen therapy after menopause (randomized trial; approved use)
  • Preventing preterm birth in high-risk pregnancies (meta-analysis and randomized trial)
  • Breast cancer risk compared with synthetic progestins in hormone therapy (cohort study)
  • Brain protection after traumatic brain injury (large randomized trials, negative)
  • Restoring periods in secondary amenorrhea (approved use)

Strength of the evidence

Approved drugOral micronized progesterone is FDA-approved for endometrial protection during estrogen therapy and for secondary amenorrhea, with vaginal forms used in fertility treatment, backed by large randomized trials.

What the literature reports on safety

The FDA label for oral progesterone lists dizziness, drowsiness, headache and breast tenderness among common effects and contraindicates it in people with unexplained vaginal bleeding, breast cancer, active or past blood clots, liver disease, or (for the capsule) peanut allergy, since it contains peanut oil. The label also carries the class warnings drawn from the Women's Health Initiative estrogen-plus-progestin trial about heart disease, stroke, breast cancer and dementia, although that trial used a synthetic progestin. Large brain-injury trials found no benefit.

Key papers

  1. Physiology, production and action of progesterone (opens in a new tab)

    Review · Taraborrelli S · Acta Obstetricia et Gynecologica Scandinavica (2015) · PMID 26358238

    Reviewed where progesterone is made, how it acts through its receptors, and its roles in the menstrual cycle and pregnancy.

  2. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials (opens in a new tab)

    Review · EPPPIC Group · Lancet (2021) · PMID 33773630

    An individual-participant meta-analysis of randomized trials found that vaginal progesterone reduced preterm birth before 34 weeks in high-risk singleton pregnancies.

  3. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial (opens in a new tab)

    Randomized trial · The Writing Group for the PEPI Trial · JAMA (1996) · PMID 8569016

    In the PEPI trial, adding progesterone or a progestin to estrogen prevented the endometrial hyperplasia that estrogen alone caused in postmenopausal women.

  4. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial (opens in a new tab)

    Randomized trial · Norman JE, Marlow N, et al. · Lancet (2016) · PMID 26921136

    In the OPPTIMUM trial, vaginal progesterone did not significantly reduce preterm birth or improve neonatal or childhood outcomes in a broad high-risk group.

  5. Very early administration of progesterone for acute traumatic brain injury (opens in a new tab)

    Randomized trial · Wright DW, Yeatts SD, et al. · The New England Journal of Medicine (2014) · PMID 25493974

    Very early intravenous progesterone did not improve outcomes after acute traumatic brain injury in the ProTECT III trial.

  6. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort (opens in a new tab)

    Cohort study · Fournier A, Berrino F, et al. · International Journal of Cancer (2005) · PMID 15551359

    In the French E3N cohort, estrogen combined with micronized progesterone was not linked to the rise in breast cancer risk seen with estrogen plus synthetic progestins over the follow-up studied.

Sources checked: PubMed/PMC (E-utilities esearch, esummary and abstracts on every PMID), FDA label (Prometrium, via openFDA), written 2026-11-06.

Hunter Williams

→ profile

Protocol systematizer

Taylor Williams

→ profile

Female-focused HRT + peptides

8 earlier videos were removed from YouTube; titles kept for the record

Dr Trevor Bachmeyer

→ profile

Acute vs chronic specialist

Sources: compound titles first, then mentions
6 earlier videos were removed from YouTube; titles kept for the record

Ask the Progesterone Librarian

Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.

What have the teachers said about Progesterone? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.

AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

Progesterone — Hunter, Taylor, Bachmeyer | Reset Biology